Shinobi Therapeutics

Shinobi Therapeutics

Biotechnology

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Visit website →View careers page →

Open Positions at Shinobi Therapeutics

0 positions available

No open positions at the moment

Check back later for new opportunities!